The Natural Health Products Directorate (NHPD) has issued letters to all L-arginine product licence holders dated March 31, 2006, advising of new information published in the Journal of the American Medical Association of possible increased mortality in patients taking natural health products containing L-arginine, when sold as a single ingredient, following an acute myocardial infarction. NHPD no longer considers these products safe for consumers with cardiovascular diseases and related disorders without a contra-indication warning statement on the label. The recommended contra-indication is to state, A Do not use if you have had a myocardial infarction (heart attack).